A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Histologically confirmed diagnosed (non-) metastatic intermediate to high grade STS
* Local recurrences are allowed
* Age ≥ 18 years
* Able and willing to undergo tumour biopsies or tumour sampling during surgery
* Localization of sarcoma enables safe biopsy or surgery
* Written informed consent

Exclusion Criteria:

* Known coagulation disorder and/or anticoagulant medication in as far it might interfere with a safe biopsy procedure (to the discretion of the treating physician and attending radiologist)
* Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the study